XHKG
2629
, Last price
HHKD
Name
MiRXES Holding Co Ltd
Chart & performance
P/E
—
P/S
—
EPS
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.
Key people
Heng Phon Too
Non-Executive Chairman of the Board · since 2021
Beng Lor Choo
Chief Financial Officer · since 2020
Hou Chiat Ho
Chief Investment Officer, Executive Director · since 2023
Lihan Zhou
Chief Executive Officer, Executive Director · since 2023
Ruiyang Zou
Deputy Chief Executive Officer, Chief Technology Officer, Executive Director · since 2022
Wei Zhi Owyong
Joint Company Secretary · since 2023
Yuet Chew Siow
Joint Company Secretary · since 2023
Beilin Le
Non-Executive Director · since 2021
Da Liu
Non-Executive Director · since 2021
Xiao Fang
Independent Non-Executive Director
Sin Lai Lam
Independent Non-Executive Director
Valuation
No data to show